Mizuho Initiates Coverage On Kura Oncology with Buy Rating, Announces Price Target of $26
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Mara Goldstein has initiated coverage on Kura Oncology (NASDAQ:KURA) with a Buy rating and set a price target of $26.
December 22, 2023 | 12:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Mara Goldstein initiated coverage on Kura Oncology with a Buy rating and a price target of $26, indicating a positive outlook for the stock.
Analyst coverage, especially with a Buy rating, can lead to increased investor interest and confidence in a stock. The price target of $26 suggests a significant upside potential from the current trading price, which could result in a short-term increase in KURA's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100